Catherine Coombs, MD, Talks Challenges with BTK Inhibitors in CLL Treatment

By Leah Sherwood - Last Updated: October 10, 2022

In this second video interview with Catherine Coombs, MD, during the 10th Annual Meeting of the Society of Hematologic Oncology (SOHO), she discusses some of the challenges remaining with Bruton’s tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia (CLL) treatment.

Post Tags:SOHO 2022
Advertisement
Editorial Board

Advertisement